This experimental pill helped people lose about 16% of their body weight after about a year of treatment ...
Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some ...
Damian Garde joins Allison, Adam, and Elaine to discuss his article about Boris Nikolic, a well-connected biotech investor ...
Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, ...
Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.
As pharmas like Eli Lilly and Roche bolster their biotech offerings, Pfizer is snuffing out its program designed to incubate new innovations from select companies, dubbed Pfizer Ignite. | As pharmas ...
Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay ...
Prasad contributed to an uncertain regulatory climate for gene therapy makers focused on rare conditions. Shares of many ...
Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...
Explore the Scaling Biotechnology and Novel Foods report to discover how industry leaders overcome regulatory, manufacturing and scale-up barriers to accelerate food innovation.
Legend Biotech (NASDAQ:LEGN) reported its Q4 earnings results on Tuesday, March 10, 2026 at 07:00 AM. Here's what investors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results